Porcelli L - Search Results

1

Prolonged exposure of colon cancer cells to the epidermal growth factor receptor inhibitor gefitinib (Iressa(TM)) and to the antiangiogenic agent ZD6474: Cytotoxic and biomolecular effects.

Azzariti A, Porcelli L, Xu JM, Simone GM, Paradiso A. Azzariti A, et al. Among authors: porcelli l. World J Gastroenterol. 2006 Aug 28;12(32):5140-7. doi: 10.3748/wjg.v12.i32.5140. World J Gastroenterol. 2006. PMID: 16937523 Free PMC article.

2

The schedule-dependent enhanced cytotoxic activity of 7-ethyl-10-hydroxy-camptothecin (SN-38) in combination with Gefitinib (Iressa, ZD1839).

Azzariti A, Xu JM, Porcelli L, Paradiso A. Azzariti A, et al. Among authors: porcelli l. Biochem Pharmacol. 2004 Jul 1;68(1):135-44. doi: 10.1016/j.bcp.2004.03.014. Biochem Pharmacol. 2004. PMID: 15183125

3

Laminin-5 offsets the efficacy of gefitinib ('Iressa') in hepatocellular carcinoma cells.

Giannelli G, Azzariti A, Fransvea E, Porcelli L, Antonaci S, Paradiso A. Giannelli G, et al. Among authors: porcelli l. Br J Cancer. 2004 Nov 29;91(11):1964-9. doi: 10.1038/sj.bjc.6602231. Br J Cancer. 2004. PMID: 15545972 Free PMC article.

4

ZD6474 inhibits proliferation and invasion of human hepatocellular carcinoma cells.

Giannelli G, Azzariti A, Sgarra C, Porcelli L, Antonaci S, Paradiso A. Giannelli G, et al. Among authors: porcelli l. Biochem Pharmacol. 2006 Feb 14;71(4):479-85. doi: 10.1016/j.bcp.2005.11.005. Epub 2005 Dec 5. Biochem Pharmacol. 2006. PMID: 16332356

5

Cyclohexylpiperazine derivative PB28, a sigma2 agonist and sigma1 antagonist receptor, inhibits cell growth, modulates P-glycoprotein, and synergizes with anthracyclines in breast cancer.

Azzariti A, Colabufo NA, Berardi F, Porcelli L, Niso M, Simone GM, Perrone R, Paradiso A. Azzariti A, et al. Among authors: porcelli l. Mol Cancer Ther. 2006 Jul;5(7):1807-16. doi: 10.1158/1535-7163.MCT-05-0402. Mol Cancer Ther. 2006. PMID: 16891467

6

Small P-gp modulating molecules: SAR studies on tetrahydroisoquinoline derivatives.

Colabufo NA, Berardi F, Cantore M, Perrone MG, Contino M, Inglese C, Niso M, Perrone R, Azzariti A, Simone GM, Porcelli L, Paradiso A. Colabufo NA, et al. Among authors: porcelli l. Bioorg Med Chem. 2008 Jan 1;16(1):362-73. doi: 10.1016/j.bmc.2007.09.039. Epub 2007 Sep 25. Bioorg Med Chem. 2008. PMID: 17936633

7

Synergic antiproliferative and antiangiogenic effects of EGFR and mTor inhibitors on pancreatic cancer cells.

Azzariti A, Porcelli L, Gatti G, Nicolin A, Paradiso A. Azzariti A, et al. Among authors: porcelli l. Biochem Pharmacol. 2008 Mar 1;75(5):1035-44. doi: 10.1016/j.bcp.2007.11.018. Epub 2007 Dec 3. Biochem Pharmacol. 2008. PMID: 18191814

8

EGFR and VEGFR as potential target for biological therapies in HCC cells.

Giannelli G, Sgarra C, Porcelli L, Azzariti A, Antonaci S, Paradiso A. Giannelli G, et al. Among authors: porcelli l. Cancer Lett. 2008 Apr 18;262(2):257-64. doi: 10.1016/j.canlet.2007.12.001. Epub 2008 Jan 11. Cancer Lett. 2008. PMID: 18248788

9

Validation of gefitinib effectiveness in a broad panel of head and neck squamous carcinoma cells.

Sebastian S, Azzariti A, Accardi R, Conti D, Pilato B, LaCalamita R, Porcelli L, Simone GM, Tommasi S, Tommasino M, Paradiso A. Sebastian S, et al. Among authors: porcelli l. Int J Mol Med. 2008 Jun;21(6):809-17. doi: 10.3892/ijmm.21.6.809. Int J Mol Med. 2008. PMID: 18506376

10

Intracellular trafficking of MDR transporters and relevance of SNPs.

Porcelli L, Lemos C, Peters GJ, Paradiso A, Azzariti A. Porcelli L, et al. Curr Top Med Chem. 2009;9(2):197-208. doi: 10.2174/156802609787521562. Curr Top Med Chem. 2009. PMID: 19200005 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

64 results

Search Page

Filters